Year in review: How did transhumanism fare in 2015?

The GLP aggregated and excerpted this blog/article to reflect the diversity of news, opinion and analysis.

A year ago, I wrote that 2014 was a great year for the transhumanism movement. But 2015 was simply incredible — it might end up being called a breakout year. I’m not yet willing to declare transhumanism as “mainstream,” but it’s getting quite close now. Transhumanism has become a word that is used frequently by people around the world and in major media when discussing radical science and technology changing our species.

One of the most in-depth profile stories this year was written by Tim Maughan of BBC Future, highlighting a day in Washington DC with Transhumanist Party members and my transhumanism speech at the World Bank. The long article was the 2nd lead story on the BBC.com for almost a full day, and also appeared in various translations on foreign BBC sites, like BBC Hindi and BBC Portugal.

Another well-read piece covering transhumanism and longevity issues this year was a Popular Science weekend feature. Also, Vox’s Dylan Matthews wrote a brilliant series of articles on transhumanism and the Immortality Bus, as did The Telegraph’s Jamie Bartlett. Additionally, CNET’s Eric Mack wrote a major story that was balanced and entertaining. TechCrunch ran a challenging article of mine on artificial intelligence, and The Daily Dot also published a fun one on my campaign and what it’s like to get a biohacker implant.

Read full, original post: Will 2015 Be Remembered as the Breakout Year for Transhumanism?

{{ reviewsTotal }}{{ options.labels.singularReviewCountLabel }}
{{ reviewsTotal }}{{ options.labels.pluralReviewCountLabel }}
{{ options.labels.newReviewButton }}
{{ userData.canReview.message }}

Related Articles

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Does glyphosate—the world's most heavily-used herbicide—pose serious harm to humans? Is it carcinogenic? Those issues are of both legal and ...

Most Popular

Screenshot-2026-03-13-at-12.14.04-PM
The FDA wants to make many popular prescription drugs OTC—a great idea. Here’s why it’s unlikely to happen
Screenshot 2026-05-06 at 2.56
Singularity crisis ahead? Can super babies save us from rogue AI geniuses?
Screenshot-2026-05-04-at-12.54.32-PM
How Utah became the country’s supplement capital  — and a haven for unregulated, ineffective and fake products
Screenshot-2026-04-20-at-2.26.27-PM
Viewpoint — Food-fear world: The latest activist scientists campaign: Cancer-causing additives
Screenshot-PM-24
Viewpoint: The herbicide glyphosate isn’t perfect. Banning it would be far worse.
images
The never-ending GMO debate: Pros and cons
Screenshot-2026-05-01-at-11.56.24-AM
‘Science moves forward when people are willing to think differently’: Memories of DNA maverick Craig Venter
Screenshot-2026-04-30-at-2.19.37-PM
5 myths about summer dehydration that could damage your health — or even kill you
Screenshot-2026-04-03-at-11.15.51-AM
Paraben panic: How a flawed study, media hype, and chemophobia convinced the public of the danger of one of the safest classes of preservatives
79d03212-2508-45d0-b427-8e9743ff6432
Viewpoint: The Casey Means hustle—Wellness woo opportunism dressed up as medical wisdom
glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.